title: Etanercept or infliximab: the patient's considerations.
authors.forename: Robert C
authors.initials: RC
authors.lastname: Sherrick
mesh_terms: D000911:Antibodies, Monoclonal / Q000191:economics / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000191:economics / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000191:economics; D000068800:Etanercept; D006801:Humans; D007074:Immunoglobulin G / Q000191:economics / Q000627:therapeutic use*; D000069285:Infliximab; D019458:Insurance Coverage / Q000191:economics; D006278:Medicare / Q000191:economics; D010358:Patient Participation; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*; D014481:United States
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000069285:Infliximab; D000068800:Etanercept